EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The effect of antibiotic prescription in non-critically ill hospitalized patients with COVID-19: A Japanese inpatient database study

Haruka Imai, Jun Suzuki, Tomoki Mizuno, Shota Takahashi, Hideya Itagaki, Makiko Yoshida, Shiro Endo, Eiichi N Kodama iD

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0318803 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Haruka Imai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan. Hauptthemen laut MEDLINE: COVID-19, Anti-Bacterial Agents, COVID-19 Drug Treatment. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, AMED-CREST.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic. Bacterial coinfections with COVID-19 occur in 3.5% of COVID-19 cases, with a higher incidence in severe cases. Although antibiotics have been prescribed to treat non-critically ill patients with COVID-19, their effect on non-critically ill hospitalized patients with COVID-19 remains uncertain.

Methods

We analyzed data from non-critically ill hospitalized patients with COVID-19 who were older than 18 years between January 1, 2020, and May 31, 2023. We performed propensity score matching analysis, evaluating in-hospital mortality with or without antibiotic prescription within 2 days of admission. Sensitivity analyses using inverse probability weighting and generalized estimating equation were also performed.

Results

Eligible patients (n = 144,110) were divided into antibiotic prescription (n = 3,873) and control (n = 140,237) groups. One-to-one propensity score matching identified 3,861 pairs of patients who received antibiotic prescriptions within 2 days of admission. Following this, antibiotic prescription was associated with a decreased 28-day mortality rate (2.3% vs. 3.6%) and in-hospital mortality rate (4.0% vs. 5.0%) compared with the control group. Conversely, antibiotics increased Clostridioides difficile infection (CDI) compared with the control group (0.6% vs. 0.1%). No statistical differences were observed between both groups regarding acute kidney injury (0.4% vs. 0.2%). Sensitivity analysis showed similar outcomes.

Conclusions

This multicenter observational study in Japan showed that antibiotic prescriptions were associated with lower 28-day and in-hospital mortalities and an increased CDI risk in non-critically ill hospitalized patients with COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Anti-Bacterial AgentsCOVID-19 Drug TreatmentHumansMaleFemaleAgedMiddle AgedHospital MortalityJapanHospitalizationSARS-CoV-2InpatientsDatabases, FactualAged, 80 and overPropensity ScoreAdultEast Asian People

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Infectious Diseases, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Division of Infectious Diseases, Tohoku Medical and Pharmaceutical University Hospital, Miyagi, Japan.
  • Department of Infection Prevention and Control, Tohoku Medical and Pharmaceutical University Hospital, Miyagi, Japan.
  • Division of Infectious Diseases and Infection Control, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan.
  • Division of Infectious Diseases and Infection Control, Department of Social and Community Medicine, Graduate School of Medicine, Tohoku Medical and Pharmaceutical University, Miyagi, Japan.
  • Division of the Crisis Management Network for Infectious Diseases, Tohoku Medical and Pharmaceutical University, Miyagi, Japan.

ORCID-Profile: Eiichi N Kodama

Förderung

  • JSPS KAKENHI
  • AMED-CREST

Zitieren

APA

Imai, H., Suzuki, J., Mizuno, T., Takahashi, S., Itagaki, H., Yoshida, M., Endo, S., & Kodama, E. N. (2025). The effect of antibiotic prescription in non-critically ill hospitalized patients with COVID-19: A Japanese inpatient database study. PLOS ONE. https://doi.org/10.1371/journal.pone.0318803

Vancouver

Imai H, Suzuki J, Mizuno T, Takahashi S, Itagaki H, Yoshida M, et al. The effect of antibiotic prescription in non-critically ill hospitalized patients with COVID-19: A Japanese inpatient database study. PLOS ONE. 2025. doi:10.1371/journal.pone.0318803

BibTeX
@article{Imai2025,
  author = {Imai, Haruka and Suzuki, Jun and Mizuno, Tomoki and Takahashi, Shota and Itagaki, Hideya and Yoshida, Makiko and Endo, Shiro and Kodama, Eiichi N},
  title = {The effect of antibiotic prescription in non-critically ill hospitalized patients with COVID-19: A Japanese inpatient database study},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0318803}
}
Kostenlos starten →